These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2084952)

  • 1. What is the effect of acetylsalicylic acid at ultra low dose on the interaction platelets/vessel wall?
    Lalanne MC; Doutremepuich C; de Sèze O; Belon P
    Thromb Res; 1990 Nov; 60(3):231-6. PubMed ID: 2084952
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy.
    Warner TD; Armstrong PC; Chan MV; Knowles RB
    Expert Rev Hematol; 2016 Mar; 9(3):223-5. PubMed ID: 26822235
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet-vessel wall interactions and drug effects.
    Twarock S; Bagheri S; Bagheri S; Hohlfeld T
    Pharmacol Ther; 2016 Nov; 167():74-84. PubMed ID: 27492900
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
    Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could proteolytic enzyme modulate the interaction platelets/vessel wall in presence of ASA at ultra low doses?
    Lalanne MC; de Seze O; Doutremepuich C; Belon P
    Thromb Res; 1991 Aug; 63(4):419-26. PubMed ID: 1754994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction.
    Buccellati C; Ciceri P; Ballerio R; Casagrande C; Folco G; Nicosia S
    Eur J Pharmacol; 2002 May; 443(1-3):133-41. PubMed ID: 12044803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief review on high on-aspirin residual platelet reactivity.
    Pettersen AA; Arnesen H; Seljeflot I
    Vascul Pharmacol; 2015; 67-69():6-9. PubMed ID: 25869498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil and aspirin modulate platelet-mediated vasomotion in arterial segments with intact or disrupted endothelium.
    Raymenants E; Yang B; Nicolini F; Behrens P; Lawson D; Mehta JL
    J Am Coll Cardiol; 1993 Sep; 22(3):684-9. PubMed ID: 8354799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct mechanisms of inhibition of platelets aggregation by acetylsalicylic acid.
    Ferri A; Calza R; Pellegrini A; Cattani L
    Biochem Mol Biol Int; 1994 Apr; 32(6):1101-7. PubMed ID: 8061627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
    Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
    Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
    González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP
    Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylsalicylic Acid Produces Different Effects on the Production of Active Oxygen Species by Activated Platelets in Different Inflammatory Diseases.
    Gabbasov ZA; Kogan-Yasny VV; Lakhno DA; Kagan LG; Ryzhkova EV; Vasilieva EY; Shpektor AV
    Bull Exp Biol Med; 2017 Nov; 164(1):36-40. PubMed ID: 29124532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro platelets/endothelial cells interactions in presence of acetylsalicylic acid at various dosages.
    Lalanne MC; Ramboer I; de Sèze O; Doutremepuich C
    Thromb Res; 1992 Jan; 65(1):33-43. PubMed ID: 1604441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclooxygenase inhibition on platelet-vessel wall interaction.
    Bourgain RH; Andries R; Maes L
    Haemostasis; 1983; 13(2):102-8. PubMed ID: 6409710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspirin resistance theory].
    Porosińska A; Pierzchała K
    Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different interactions of platelets with arterial and venous coronary bypass vessels.
    Yang ZH; Stulz P; von Segesser L; Bauer E; Turina M; Lüscher TF
    Lancet; 1991 Apr; 337(8747):939-43. PubMed ID: 1678031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish oil and the platelet-blood vessel wall interaction.
    Vanhoutte PM; Shimokawa H; Boulanger C
    World Rev Nutr Diet; 1991; 66():233-44. PubMed ID: 2053340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.